Aveanna Healthcare Holdings Inc

Aveanna Healthcare Holdings Inc(AVAH)股票分析

$12.340

-0.292 (-2.37%)收盤時

Loading chart…
最高
12.720
開盤
12.650
成交量加權均價
12.44
成交量
2.33M
市值
492.49M
最低
12.250
成交金額
28.94M
企業價值/稅息折舊攤銷前利潤(TTM)
10.42

Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. The Company's segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. The HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. The Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The MS business serves patients who have short or long-term disabilities and require a supply of infant, pediatric and adult formulas.

AI 分析 of Aveanna Healthcare Holdings Inc (AVAH)

持有

Aveanna Healthcare is currently a hold. The stock has a current price of $12.25, which is below the analyst price target of $15, suggesting potential upside. However, the RSI is at 32.085, indicating that the stock is oversold, which could mean a price rebound is possible. The recent insider selling has increased by 675.38%, which raises concerns about the stock's immediate outlook. Therefore, while there is potential for long-term gains, the current market sentiment and technical indicators suggest caution.

估值指標

Aveanna Healthcare Holdings Inc(AVAH)目前預期本益比為 13.32,5 年平均預期本益比為 37.40。

預期本益比

合理
5 年均值 P/E
37.40
目前P/E
13.32
高估
140.10
低估
-65.29

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
11.87
目前EV/EBITDA
10.42
高估
13.41
低估
10.32

預期股價營收比

嚴重高估
5 年均值 P/S
0.41
目前P/S
0.93
高估
0.65
低估
0.17

Alphio AI 對 AVAH 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%AVAH

$6.77

情境價格

基

基準

基準 · 50%AVAH

$6.66

情境價格

悲

悲觀

悲觀 · 25%AVAH

$6.42

情境價格

持有 AVAH 的大戶

B

Braidwell LP

+ 持有AVAH

+15.28%

3個月報酬率

J

Jaunty Global Limited

+ 持有AVAH

-1.42%

3個月報酬率

事件時間軸

2026-08-20 (ET)

21:00:00

RBC Capital Prices Deal Within $11.65-$11.90 Range

20:00:00

US Treasury Yields Rise, Dow Drops Over 700 Points

16:30:00

Aveanna Healthcare Launches Secondary Offering of 15 Million Shares

2026-08-13 (ET)

07:30:00

Aveanna Raises FY26 Adjusted EBITDA Outlook to Over $365M

07:30:00

Aveanna Reports Q2 Revenue of $670.48M, Exceeds Expectations

資訊

AVAH 常見問題 —— 由 Alphio AI 解答

Aveanna Healthcare Holdings Inc. is a provider of diversified home care platforms. The Company's segments include Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment includes private duty nursing (PDN) services, as well as pediatric therapy services. The HHH segment includes home health services, as well as hospice and specialty program services. Its home health services involve the provision of in-home services to its patients by its clinicians, which include nurses, therapists, social workers and home health aides. Its hospice services involve a supportive philosophy and concept of care for those nearing the end of life. The Medical Solutions segment offers a line of enteral nutrition supplies and other products to adults and children, delivered on a periodic or as-needed basis. The MS business serves patients who have short or long-term disabilities and require a supply of infant, pediatric and adult formulas. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).

Aveanna Healthcare is currently a hold. The stock has a current price of $12.25, which is below the analyst price target of $15, suggesting potential upside. However, the RSI is at 32.085, indicating that the stock is oversold, which could mean a price rebound is possible. The recent insider selling has increased by 675.38%, which raises concerns about the stock's immediate outlook. Therefore, while there is potential for long-term gains, the current market sentiment and technical indicators suggest caution.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易